Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LM-061 in Advanced Tumors
NCT04882176Phase 2Terminated
- Sponsor
- LaNova Medicines
- Start
- May 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LM-061 in solid tumor (advanced stage), sponsored by LaNova Medicines. Started May 2021; status: terminated.
02
Drugs
LM-061
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT04882176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04882176.